Gertjan Kaspers
Pediatric Oncologist · Department of Pediatrics, VU University Medical Center Amsterdam De Boelelaan 1117, NL-1081 HV Amsterdam, The Netherlands
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gertjan Kaspers as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:20 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06262438 · CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML PatientsPrincess Maxima Center for Pediatric Oncology · recruiting · Acute Myeloid Leukemia in Children · study chair
- Ph3NCT05994690 · CHIP-AML22/Master: An Open Label Complex Clinical Trial in Newly Diagnosed Pediatric de Novo AML PatientsPrincess Maxima Center for Pediatric Oncology · recruiting · Acute Myeloid Leukemia in Children · study chair
- Ph3NCT01828489 · Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 YearsVastra Gotaland Region · unknown · Pediatric Acute Myeloblastic Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:20 UTC. The ranking covers the 200 most relevant of 50 PubMed records, and a shared surname and initials can bring in a namesake. All 50 on PubMed
- 308 citationsRCR 6.2
- 252 citationsRCR 5.6
- Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group.J Clin Oncol · 2013186 citationsRCR 5.5
- 181 citationsRCR 5.8
- 109 citationsRCR 2.5
- 107 citationsRCR 2.5
- Longitudinal development of cancer-related fatigue and physical activity in childhood cancer patients.Pediatr Blood Cancer · 201979 citationsRCR 4.4
- 77 citationsRCR 1.6
- 72 citationsRCR 1.5
- Cardiorespiratory fitness and physical activity in children with cancer.Support Care Cancer · 201670 citationsRCR 3.4